Oraqix and Maculopathy - from FDA reports
There is no Maculopathy reported by people who take Oraqix yet. This review analyzes which people have Maculopathy with Oraqix. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 21, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Maculopathy when taking Oraqix?
- Check symptoms - is maculopathy caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsMaculopathy and drugs with ingredients of lidocaine; prilocaine.
Expand the study to include reports from both FDA and eHealthMeMaculopathy and Oraqix from FDA and eHealthMe reports
Oraqix has active ingredients of lidocaine; prilocaine. (latest outcomes from Oraqix 30 users)
Maculopathy (condition or disease of the macula, the small spot in the retina where vision is keenest) has been reported by people with high blood pressure, rheumatoid arthritis, multiple sclerosis, osteoporosis, maculopathy (latest reports from 2,094 Maculopathy patients).